Home > Insider Trading > Filing (0001181431-11-055339)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1484478	Furiex Pharmaceuticals Inc.	FURX	Pharmaceutical Preparations (2834)	271197863

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1492648	H Marshall Woodworth	C/O Furiex Pharmaceuticals, Inc. 3900 Paramount Parkway, Suite 150 Morrisville NC 27560	Chief Financial Officer	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2011-11-04	6,211	$14.78	6,211	No	4	P	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	P	Direct

Reported Derivative Holdings

Sec. Name	Sec. Type	Price	Expiration Date	Amount	Remaning Holdings	Nature of Ownership
Common Stock	Stock Option (to buy)	$13.16	2021-10-03	29,644	29,644	Direct
Common Stock	Stock Options (to buy)	$15.00	2021-05-09	26,000	26,000	Direct
Common Stock	Stock Options (to buy)	$9.11	2020-06-17	49,407	49,407	Direct

Expiration Date	Amount	Remaning Holdings	Nature of Ownership
2021-10-03	29,644	29,644	Direct
2021-05-09	26,000	26,000	Direct
2020-06-17	49,407	49,407	Direct

Footnotes

The options were awarded on 10/3/2011 and vest over three years, with one-third vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's employment continues.
The options were awarded on 5/9/2011. One-third of the options vest on the date of grant and the remaining two-thirds vest in two equal annual installments on the first and second anniversaries of the date of grant, provided the Optionee's employment continues.
The options were awarded on 6/17/2010 and vest over three years, with one-third vesting on each of the first, second and third anniversaries of the date of grant, provided the Optionee's employment continues.